Kedrion Biopharma

🌍 𝐄𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐄𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐁𝐥𝐞𝐞𝐝𝐢𝐧𝐠 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐌𝐫. 𝐆𝐚𝐫𝐫𝐢𝐝𝐨, 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐨𝐟 𝐖𝐅𝐇 During the 𝟐𝟎𝟐𝟒 𝐖𝐨𝐫𝐥𝐝 𝐅𝐞𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐇𝐞𝐦𝐨𝐩𝐡𝐢𝐥𝐢𝐚 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬, we had the privilege of speaking to Mr. Garrido (President of World Federation of Hemophilia / Fédération mondiale de l'hémophilie), about a critical topic affecting patients globally: 𝐞𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬. In our interview, he shared compelling perspectives on why this issue matters and what steps can be taken to bridge gaps in care. Bleeding disorders are a condition that require lifelong management, and access to therapies can significantly impact patients' lives. As advocates for health equity, it's crucial to address disparities in access, ensuring that everyone, regardless of location or resources, can receive the treatments they need. More than 3000 attendees gathered at this year’ World Federation of Hemophilia Congress, recently held in Madrid, as it is recognized as one of the most important appointments for the bleeding disorders communities. ⤵️ 𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐡𝐞𝐫𝐞 to gain valuable insights. #WFHCongress2024 #TreatmentForAll #GlobalHealth #BleedingDisorder

🌟 𝟏𝟎𝟎 𝐘𝐞𝐚𝐫𝐬 𝐨𝐟 𝐬𝐞𝐫𝐯𝐢𝐧𝐠 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬: 𝐊𝐞𝐝𝐫𝐢𝐨𝐧 𝐡𝐨𝐧𝐨𝐫𝐬 𝐭𝐡𝐞 𝐋𝐞𝐠𝐚𝐜𝐲 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐨𝐟 𝐨𝐮𝐫 𝐆𝐨̈𝐝𝐨̈𝐥𝐥𝐨̋ 𝐬𝐢𝐭𝐞. 🌟 This year, our production site located in Gödöllő, near Budapest, Hungary, proudly celebrates its 100th anniversary. For a century, this facility has been a cornerstone of healthcare advancement in the country, driven by continuous innovation and a commitment to pushing the boundaries of research for the benefit of patients. Kedrion acquired this facility in 2008, making it a key player in its global industrial network, building strong relationships with the local communities and distinguishing itself for its commitment to the region. Yesterday, celebrations of this incredible milestone kicked off at the site with a crowded grand opening hosted by Laszlo Siadik, Managing Director of our Hungarian subsidiary, a message from our CEO Ugo Di Francesco and the presence - among others - of Gödöllő's Mayor, György Gémesi. This 100-year history wouldn't have been possible without the dedication of all who came before us. A special thanks to our employees who work every day to transform plasma into life-saving therapies.

Bob Rossilli, CCO of Kedrion Biopharma - USA, explains the benefits of membership with the Plasma Protein Therapeutics Association. Ready to become a member? Click here to get started: https://lnkd.in/emRt8ddF

Motherhood. It's a whirlwind of sticky kisses, sleepless nights, and a love that defies definition. But let's be honest, it's also hard. For working moms, the daily juggle is real. From managing conference calls with spit-up stains on blouses, negotiating deadlines with one hand rocking a fussy baby, and somehow finding the strength to be everything to everyone - at home and at work. At Kedrion Biopharma, we see you. We see the strength it takes to navigate the complexities of motherhood, especially when facing the additional challenge of a rare disease. To all the mothers fighting for their children's health, we stand with you. You are warriors, nurturers, and miracle makers. This Mother's Day, and every day, we celebrate the extraordinary strength of mothers. Let's lift each other up, share our stories, and keep pushing for a brighter future for all. If you want to learn more about how we stay connected to our communities and support mothers facing daily battles with their children's rare diseases, visit the "Our Stories" section on kedrion.com. *Yes, this is a reality check – in the photo you see one of our leaders handling a call while being a mother

It is particularly important 𝐢𝐧 𝐫𝐚𝐫𝐞 𝐚𝐧𝐝 𝐮𝐥𝐭𝐫𝐚-𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞, that all those involved, from scientific bodies to patient associations, from industry players to key opinion leaders, work together with a double goal - raising general awareness of the disease, its consequences, and educating physicians and healthcare providers to recognize the symptoms and reach a diagnosis sooner. To mark the 𝐟𝐢𝐫𝐬𝐭 𝐂𝐨𝐧𝐠𝐞𝐧𝐢𝐭𝐚𝐥 𝐏𝐥𝐚𝐬𝐦𝐢𝐧𝐨𝐠𝐞𝐧 𝐃𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐃𝐚𝐲, promoted globally on May 4th, we would like to recognize everyone at our Laval, Canada, manufacturing site for their long-standing committment to 𝐦𝐚𝐤𝐢𝐧𝐠 𝐚 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐥𝐢𝐯𝐞𝐬 𝐨𝐟 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 struggling with Congenital Plasminogen Deficiency.

✨ We are thrilled to announce our new 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐝𝐞 𝐨𝐟 𝐂𝐨𝐧𝐝𝐮𝐜𝐭. ✨ 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲 is one of the foundational Values of our Company. The Kedrion Global Code of Conduct reflects the commitment by our 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 and 𝐄𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬 to each other and our stakeholders to take the right decisions and to do the right thing as part of our daily job. 𝐒𝐮𝐩𝐩𝐥𝐢𝐞𝐫𝐬 and 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬 working with us are expected to share our same values and commitment. ➡️ Have a look at our 𝐂𝐨𝐝𝐞 and let us have your thoughts! https://lnkd.in/dumMUAzj

✨🚀 On 24 April the European Parliament approved the substances of human origin (SoHO) regulation. As a company that puts the health and well-being of donors and patients first, we are very satisfied with this result, which will have a positive and real impact on #plasma collection and donor safety. The SoHO regulation is an important milestone for #patients across #European Union (EU) who rely on plasma-derived medicines. 🎤 Ferdinando Borgese stated that, "This regulation promises a significant increase in plasma availability, a critical resource for life-saving medicines. By guaranteeing a secure supply within Europe, it can enable a substantial rise in plasmapheresis donations, ultimately benefiting countless patients who rely on these treatments. We remain committed to collaborating with the public and third sectors to ensure donor health."

☑️ Early diagnosis and treatment can prevent complications and enable people to live as normal a life as possible. ☑️ Early diagnosis contributes greatly to improved quality of life and care for people with PI ☑️ Patient access to care and appropriate treatment can help prevent serious and life-threatening illnesses in people with PI With this in mind, the video campaign “AFFIANCO” ("walk together”) narrated the extraordinary and touching experiences of five patients and their referring doctors, who, from a certain moment of their existence, began to "walk together" in the difficult battle against Primary Immunodeficiencies (PID), rare diseases of the immune system. The initiative was conceived and developed by the Associazione Nazionale Immunodeficienze Primitive - AIP O.d.V. (Italian Association of Primary Immunodeficiencies - AIP O.d.V.) and supported by Kedrion with an unconditional grant. 🎥 Watch the stories: https://lnkd.in/dPyhpUYE [TIP: Click on the automatic subtitles on youtube for more languages] #WorldPIWeek #WorldPIWeek2024 #PIDs #PrimaryImmunodeficiency #RaiseAwareness

Join World PI Week as we navigate through the complexities of PIDs, raising awareness and empowering communities to recognize the signs, access timely diagnosis, and receive optimal care. Together, let's amplify our efforts to ensure that no one affected by PIDs is left behind. #WorldPIWeek #WorldPIWeek2024 #PIDs #PrimaryImmunodeficiency #RaiseAwareness

🌟🌍 𝐒𝐭𝐞𝐩 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭: 𝐈𝐭'𝐬 World PI Week 𝟐𝟎𝟐𝟒! 🌍🌟 🔍 Did you know that around the world: 80% of primary immunodeficiency patients do not have access to adequate care yet? 💪 This week, we're joining hands globally to illuminate the path towards better understanding and support for those living with Primary Immunodeficiency (PI) disorders. 🌟 At Kedrion, we're dedicated to pioneering advancements in PI research and developing life-changing therapies. Every day, we're inspired by the resilience and strength of the PI community, and we stand shoulder to shoulder with them in their journey. 🤝 Join us this World PI Week as we unite to celebrate the unsung heroes, caregivers, researchers, and advocates who tirelessly champion the cause of PI awareness and support. Together, let's make a difference and ensure that no one faces PI alone. 💡 Stay tuned for inspiring stories, informative resources, and exciting updates throughout the next weeks. Let's shine a light on PI and illuminate hope for a brighter, healthier future! #WorldPIWeek #WorldPIWeek2024 #PIDs #PrimaryImmunodeficiency #RaiseAwareness https://lnkd.in/dz4PEy_z